BLOOD SCIENCE FOUNDATION (BSF) PROVIDES FUNDING DIRECTLY TO VITALANT TO SUPPORT THE MISSION OF THE ORGANIZATION, IN AN AMOUNT EQUALING OR EXCEEDING THE DISTRIBTUABLE AMOUNT AS DESCRIBED IN TREASURY REGULATION 1.509(A)-4(I)(5)(II). BSF FUNDED COVID-19 ANTIBODY TESTING FOR BLOOD DONORS FROM JULY 2020 THROUGH NOVEMBER 2020. THE AMOUNT PAID TO VITALANT TO COVER THE COSTS OF THE TESTING IN ITS CHICAGO AND PITTSBURGH OPERATIONS WAS $787,868.
DatesJul 1, 2020 – Jun 30, 2021
